Ortivus AB
STO:ORTI B
Intrinsic Value
Ortivus AB engages in the development and sale of clinical devices and systems. [ Read More ]
The intrinsic value of one ORTI B stock under the Base Case scenario is 2.49 SEK. Compared to the current market price of 2.53 SEK, Ortivus AB is Overvalued by 2%.
Valuation Backtest
Ortivus AB
Run backtest to discover the historical profit from buying and selling ORTI B stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Ortivus AB
Current Assets | 33.9m |
Cash & Short-Term Investments | 1.3m |
Receivables | 11.2m |
Other Current Assets | 21.4m |
Non-Current Assets | 33m |
Long-Term Investments | 4m |
PP&E | 5.2m |
Intangibles | 23.8m |
Current Liabilities | 38.5m |
Accounts Payable | 9.3m |
Accrued Liabilities | 13.8m |
Short-Term Debt | 8m |
Other Current Liabilities | 7.4m |
Non-Current Liabilities | 12.8m |
Long-Term Debt | 3.2m |
Other Non-Current Liabilities | 9.6m |
Earnings Waterfall
Ortivus AB
Revenue
|
78.1m
SEK
|
Cost of Revenue
|
-51.7m
SEK
|
Gross Profit
|
26.5m
SEK
|
Operating Expenses
|
-46.6m
SEK
|
Operating Income
|
-20.1m
SEK
|
Other Expenses
|
-477k
SEK
|
Net Income
|
-20.6m
SEK
|
Free Cash Flow Analysis
Ortivus AB
ORTI B Profitability Score
Profitability Due Diligence
Ortivus AB's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
Score
Ortivus AB's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
ORTI B Solvency Score
Solvency Due Diligence
Ortivus AB's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Score
Ortivus AB's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ORTI B Price Targets Summary
Ortivus AB
Shareholder Return
ORTI B Price
Ortivus AB
Average Annual Return | 39.14% |
Standard Deviation of Annual Returns | 51.18% |
Max Drawdown | -71% |
Market Capitalization | 112.1m SEK |
Shares Outstanding | 44 310 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Ortivus AB engages in the development and sale of clinical devices and systems. The company is headquartered in Danderyd, Stockholm. The firm is engaged in the development of mobile surveillance and communication solutions, forming a decision support system. Its offering comprises: MobiMed Smart, a decision support system, which allows ambulance personnel to handle documentation, monitoring and introduce a structured approach in prehospital care; CoroNet, a mobile surveillance solution which allows patients to move freely under supervision of medical staff and provides healthcare professionals with monitoring information. In addition, the Company provides a wide range of services, such as support, implementation, training and consulting, among others. The Company’s customer base includes mainly ambulance services and emergency departments.
Contact
IPO
Employees
Officers
The intrinsic value of one ORTI B stock under the Base Case scenario is 2.49 SEK.
Compared to the current market price of 2.53 SEK, Ortivus AB is Overvalued by 2%.